ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ICCM vs BJDX // RSI-14 & 200D SMA MOMENTUM

IceCure Medical Ltd. (NASDAQ) VS. Bluejay Diagnostics Inc. (NASDAQ) • 15-METRIC TALLY: ICCM 3 — BJDX 0
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ICCM
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICCM VS. BJDX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ICCM BJDX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 36.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 2.70% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 3/9 +2.00 ICCM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 28.5 28.2 +0.30 ICCM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.3M $2.4M $863.9K ICCM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ICCM REV BJDX REV ICCM GROSS % BJDX GROSS % ICCM FCF BJDX FCF
FY 2025 $3.4M $0 36.3% — -$14.6M -$6.2M
FY 2024 $3.3M $0 44.1% — -$12.6M -$8.1M
FY 2023 $3.2M $0 — — -$12.6M -$8.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICCM // BETA —
BJDX // BETA —